The current state of apps and wearables for supporting peri/menopausal individuals: a systematic review

For decades, the years leading up to the end of a woman's reproductive life have been a medical blind spot. This transition, known as perimenopause, is a time when the body's hormone levels shift unpredictably, bringing a wide array of symptoms that can range from sudden waves of heat to sleepless nights, mood swings, and brain fog. Unlike a single event, this phase is a long, winding road that can last for years, during which symptoms often overlap with other health issues, making it difficult for individuals to know what is happening to them or how to find relief. Because clinical guidance has historically been inconsistent, many people have turned to their smartphones and wearable devices, hoping that technology could offer the clarity and support that doctors have not yet provided. These digital tools, which include apps and smart rings, promise to track the body's subtle signals and turn raw data into understandable insights.

A recent systematic review set out to examine the current landscape of these digital health tools specifically designed for this stage of life. The researchers wanted to know what is actually available in the app stores, how these tools function, and whether there is any solid proof that they actually help people manage their symptoms. They scoured academic databases and the major mobile app marketplaces, looking for any software or device that claimed to track perimenopause or menopause symptoms, offer educational content, or provide personalized guidance. Their search covered a decade of development, from 2015 to 2025, capturing both the published scientific studies and the commercial products currently on the market.

What they found was a marketplace that has become crowded very quickly, yet remains largely unproven. The review identified eighty distinct mobile applications that target women navigating this transition. Almost all of these apps, about ninety-six percent, allow users to log their symptoms manually, such as recording the intensity of a hot flash or the quality of their sleep. Many of these tools also offer educational articles to help users understand what is happening to their bodies, and more than half now use artificial intelligence to analyze the data and offer personalized suggestions. A smaller portion of the apps, about twenty-eight percent, can connect to wearable devices like smart rings or fitness trackers to gather data automatically, such as heart rate or skin temperature, without the user having to type anything in.

Despite this rapid growth and the promise of high-tech solutions, the review highlighted a significant gap between the number of available tools and the evidence supporting them. Only five percent of the eighty apps included in the study had been evaluated in a published scientific paper to show that they actually improve health outcomes. While a few studies suggested that using certain apps could reduce the distress caused by hot flashes or improve sleep quality, the vast majority of these tools have not been tested in rigorous trials. The researchers noted that many apps claim to use complex algorithms to predict a woman's stage of menopause or identify triggers for her symptoms, but the details of how these calculations work are often kept secret, leaving users and doctors unsure of how reliable the advice really is.

The review also pointed out that while these tools are becoming more sophisticated, they often rely heavily on the user to keep logging data every day. If a person stops tracking for a few weeks, the patterns the app tries to identify can disappear. Furthermore, the study raised concerns about who can access these tools. Many of the most advanced devices, such as smart rings or hormone testing kits, can be expensive, potentially leaving out women from lower-income backgrounds who might benefit most from the support. There were also questions about how the sensitive health data collected by these apps is stored and protected, with many companies offering little transparency about their privacy practices.

Ultimately, the paper concludes that while the digital health market for perimenopause is expanding rapidly and offers a variety of features from symptom tracking to community support, it is currently built on a foundation of limited evidence. The tools exist and are being used by many, but we do not yet know for sure which ones are the most effective or how they should be used to get the best results. The authors suggest that for these technologies to truly help, the industry needs to focus more on rigorous testing, clearer explanations of how their artificial intelligence works, and designs that are accessible to a diverse range of women. Until then, these apps remain a hopeful but unverified resource for a transition that deserves better support.